17954709

Source:http://linkedlifedata.com/resource/pubmed/id/17954709

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006142, umls-concept:C0034866, umls-concept:C0041365, umls-concept:C1515948, umls-concept:C1519814, umls-concept:C1524063
pubmed:issue	33
pubmed:dateCreated	2007-11-20
pubmed:abstractText	To update the recommendations for the use of tumor marker tests in the prevention, screening, treatment, and surveillance of breast cancer.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/17954709-18421062, http://linkedlifedata.com/resource/pubmed/commentcorrection/17954709-18421063
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Tumor-Associated..., http://linkedlifedata.com/resource/pubmed/chemical/CA 27-29 antigen, http://linkedlifedata.com/resource/pubmed/chemical/Carcinoembryonic Antigen, http://linkedlifedata.com/resource/pubmed/chemical/Cathepsin D, http://linkedlifedata.com/resource/pubmed/chemical/Cyclin E, http://linkedlifedata.com/resource/pubmed/chemical/ERBB2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Mucin-1, http://linkedlifedata.com/resource/pubmed/chemical/Plasminogen Activator Inhibitor 1, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53, http://linkedlifedata.com/resource/pubmed/chemical/Urokinase-Type Plasminogen Activator
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	1527-7755
pubmed:author	pubmed-author:American Society of Clinical Oncology, pubmed-author:BastRobert CRCJr, pubmed-author:FritscheHerbertH, pubmed-author:HarrisLyndsayL, pubmed-author:HayesDaniel FDF, pubmed-author:MennelRobertR, pubmed-author:NortonLarryL, pubmed-author:RavdinPeterP, pubmed-author:SomerfieldMark RMR, pubmed-author:TaubeSheilaS
pubmed:issnType	Electronic
pubmed:day	20
pubmed:volume	25
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	5287-312
pubmed:dateRevised	2009-11-19
pubmed:meshHeading	pubmed-meshheading:17954709-Antigens, Tumor-Associated, Carbohydrate, pubmed-meshheading:17954709-Bone Marrow, pubmed-meshheading:17954709-Breast Neoplasms, pubmed-meshheading:17954709-Carcinoembryonic Antigen, pubmed-meshheading:17954709-Cathepsin D, pubmed-meshheading:17954709-Cell Proliferation, pubmed-meshheading:17954709-Cyclin E, pubmed-meshheading:17954709-Drug Resistance, Neoplasm, pubmed-meshheading:17954709-Female, pubmed-meshheading:17954709-Gene Expression Profiling, pubmed-meshheading:17954709-Humans, pubmed-meshheading:17954709-Mucin-1, pubmed-meshheading:17954709-Neoplastic Cells, Circulating, pubmed-meshheading:17954709-Plasminogen Activator Inhibitor 1, pubmed-meshheading:17954709-Practice Guidelines as Topic, pubmed-meshheading:17954709-Proteomics, pubmed-meshheading:17954709-Receptor, erbB-2, pubmed-meshheading:17954709-Receptors, Estrogen, pubmed-meshheading:17954709-Receptors, Progesterone, pubmed-meshheading:17954709-Tumor Markers, Biological, pubmed-meshheading:17954709-Tumor Suppressor Protein p53, pubmed-meshheading:17954709-Urokinase-Type Plasminogen Activator
pubmed:year	2007
pubmed:articleTitle	American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.
pubmed:affiliation	Yale Cancer Center, Yale University, New Haven, CT, USA.
pubmed:publicationType	Journal Article, Review